High-Dose Tranexamic Acid in Patients Underwent Surgical Repair of Aortic Dissection Might Reduce Postoperative Blood Loss: A Cohort Analysis

INTRODUCTION: While tranexamic acid (TXA) is widely used in patients with acute type A aortic dissection (ATAAD) who undergo surgical repair to reduce blood loss and transfusion requirement, the optimal dosage of TXA is unknown in these patients. MATERIALS AND METHODS: This was a retrospective cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jingfei, Cao, Liang, Wang, Hongbai, Liu, Guangyu, Zhou, Yong, Yang, Lijing, Jia, Yuan, Yuan, Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237523/
https://www.ncbi.nlm.nih.gov/pubmed/35774387
http://dx.doi.org/10.3389/fsurg.2022.898579